Skip to main content
Clinical Trials/NCT06488339
NCT06488339Not yet recruitingNot Applicable

Efficacy and Safety of Food Replacement on Weight Control in Overweight Volunteers

Chulalongkorn University0 sites60 target enrollmentStarted: July 15, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
60
Primary Endpoint
Weight

Study Overview

Brief Summary

Volunteers will be divided into two groups which are protein and oil supplement group and normal dietary group. For protein and oil supplement group, they will take 1 sachet of product replaced dinner every day for 8 weeks. For normal dietary group, they will take regular dinner every day for 8 weeks. Weight, body mass index, body composition, waist and hip circumference, skin fold thickness, and chemistry in blood will be evaluated.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age 18-60 years
  • •Body mass index more than 23 kg/m2
  • •No heart disease, diabetes mellitus, thyroid disease, cancer, liver and kidney diseases
  • •Wiling to attend the study

Exclusion Criteria

  • •Allergic to protein, grains, guar gum
  • •Take medicine, supplement, herbal substance for weight control within 1 month
  • •During intermittent fasting
  • •Take birth control pill, steroids, anti-depressant drugs, and anti-epilepsy drugs
  • •Cushing syndrome's
  • •Pregnancy and lactation

Arms & Interventions

Protein and oil supplement

Experimental

Take 1 sachet/day replaced dinner

Intervention: Protein and oil supplement (Dietary Supplement)

Normal dietary meal

No Intervention

Take normal dietary meal for dinner

Outcomes

Primary Outcomes

Weight

Time Frame: 8 weeks

Weight of volunteers (kg)

Secondary Outcomes

  • Percentage of body fat(8 weeks)
  • Body mass index(8 weeks)
  • Hemoglobin A1C(8 weeks)
  • Total protein(8 weeks)
  • Percentage of visceral fat(8 weeks)
  • Percentage of subcutaneous fat(8 weeks)
  • Percentage of muscle(8 weeks)
  • Hip Circumference(8 weeks)
  • Total cholesterol(8 weeks)
  • Waist Circumference(8 weeks)
  • Skin fold thickness(8 weeks)
  • Low density lipoprotein(8 weeks)
  • Triglycerides(8 weeks)
  • 8-hydroxy-2-deoxyguanosine(8 weeks)
  • High density lipoprotein(8 weeks)
  • Fasting blood sugar(8 weeks)
  • Hemoglobin(8 weeks)
  • SIRT1 (NAD-dependent deacetylase sirtuin-1)(8 weeks)
  • Blood urea nitrogen(8 weeks)
  • Alanine aminotransferase(8 weeks)
  • Creatinine(8 weeks)
  • Aspartate transaminase(8 weeks)
  • Alkaline phosphatase(8 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Pornanong Aramwit, Pharm.D., Ph.D

Professor

Chulalongkorn University

Similar Trials